Table 6. Disease-free survival of metastasis tumor.
Approaches | Study | N | DFS (months) | Survival Rate | |||
---|---|---|---|---|---|---|---|
1-year | 2-year | 3-year | 5-year | ||||
Thoracotomy | Mutsaerts et al 2002[22] | 19 | <10 | — | 42 | — | — |
Thoracotomy | Nakajima et al 2008[2] | 71 | 27 | 57.6 | — | 26.2 | 21.1 |
Thoracotomy | Carballo et al 2009[15] | 135 | 24.8 | 87.4 | — | 67.9 | 58.8 |
Thoracotomy | Nakas et al 2009[12] | 27 | 29 | — | — | — | — |
VATS | Mutsaerts et al 2002[22] | 16 | <10 | — | 50 | — | — |
VATS | Nakajima et al 2008[2] | 72 | 23.8 | 64.6 | — | 42.6 | 34.4 |
VATS | Carballo et al 2009[15] | 36 | 25.6 | 91.7 | — | 69.6 | 69.6 |
VATS | Nakas et al 2009[12] | 25 | 20 | — | — | — | — |
Transxiphoid HATS | Mineo et al 2001[24] | 29 | 19 | — | — | — | — |
Transxiphoid HATS | Mineo et al 2007[25] | 71 | 12 | — | — | — | — |
Our HATS | Current study | 65 | 27.4 | 84.4 | 61.8 | 44.3 | 31.9 |
N: Number of cases.
—: No data obtained.